摘要
目的分析对重症肺炎患者采用无创双水平正压通气联合痰液引流治疗的临床效果。方法选取2012年1月∽2014年6月在我院确诊为肺炎的重症患者140例作为研究对象,将患者分为对照组和观察组两组,以随机数字表法为分组原则,每组70例患者,对照组患者采用单纯的无创双水平正压通气治疗,观察组患者在对照组的基础上联合痰液引流治疗,对两组的应用效果进行比较。结果观察组患者呼吸支持时间（84.91±11.15）h、住院天数（14.65±1.32）d均少于对照组呼吸支持时间（124.30±14.55）h、住院天数（25.70±0.75）d,差异有统计学意义（P〈0.05）;观察组治疗后的并发症发生率（15.72%）明显低于对照组治疗后的并发症的发生率（42.87%）,两组比较差异统计学意义（P〈0.05）。结论重症肺炎患者在采用无创双水平正压通气治疗的基础上联合应用痰液引流的治疗效果较好,缩短了患者的呼吸支持时间和住院时间,降低了患者的并发症发生率,有利于患者的康复和预后、值得推广应用。
ObjectiveTo explore the effect of noninvasive bilevel pressure ventilation combined with mucus drainage used in severe pneumonia patients. Methods 140 cases were selected from our hospital from January 2012 to June 2014, they were randomly divided into a control group and observation group, each group had 70 patients, the control group patients were treated with a simple non-invasive bi-level positive airway pressure, observation group patients were treat with noninvasive bilevel pressure ventilation combined with mucus drainage and then application results of two groups were compared.Results In observation group, respiratory support time was （84.91±11.15） h, length of hospital stay was （14.65±1.32） days, in control group, respiratory support time was （124.30±14.55）h, length of hospital stay was （25.70±0.75）days, and observation group were better than the control group in the two aspects, the difference were statically significant（P〈0.05）; Complication rate of observation group was 15.72%,which was lower than the control group（42.87%）, the difference were statically significant （P〈0.05）.Conclusion Noninvasive bilevel pressure ventilation combined with mucus drainage can shorten the pneumonia patient＆#39;s respiratory support and hospital stay,can reduce the complication rate,is good for patients＆#39; ehabilitation and prognosis,so it is worth to promote in clinical.
出处
《中国医药科学》
2015年第11期196-198,共3页
China Medicine And Pharmacy
关键词
重症肺炎
无创双水平正压通气
痰液引流
应用效果
Severe pneumonia
Noninvasive bilevel pressure ventilation
Sputum drainage
Application effect
